Resolution of Left Bundle Branch Block With Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction

被引：1
|
作者：
Abudan, Anas
Parimi, Nikhil
Sami, Farhad
Mahmood, Uzair
Schwarz, Colton
Pierpoline, Michael
Mohammed, Moghniuddin
Dendi, Raghuveer
Pimentel, Rhea C.
Berenbom, Loren D.
Emert, Martin
Ramirez, Rigoberto
Noheria, Amit
Reddy, Madhu
Sauer, Andrew J.
Gupta, Bhanu
Sheldon, Seth H.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
10.1161/circ.142.suppl_3.16271
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16271
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu
    American Journal of Cardiovascular Drugs, 2018, 18 : 473 - 482
  • [32] Economic evaluation of sacubitril/valsartan for the treatment of heart failure with reduced ejection fraction
    Stafylas, P.
    Farmakis, D.
    Giamouzis, G.
    Hatzikou, M.
    Kourlaba, G.
    Papatsouma, I.
    Maniadakis, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 730 - 731
  • [33] Incidence and prognostic impact of new-onset left bundle branch block in patients with heart failure and reduced ejection fraction
    Kristensen, S. L.
    Roerth, R.
    Jhund, P. S.
    Beggs, S.
    Kober, L.
    Abraham, W. T.
    Desai, A.
    Solomon, S.
    Packer, M.
    Rouleau, J.
    Zile, M.
    Dickstein, K.
    Petrie, M. C.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1587 - 1587
  • [34] Sacubitril/Valsartan in the primary treatment of heart failure with reduced ejection fraction (HFrEF)
    Nowak, Bernd
    Geiss, Ernst
    Boehm, Michael
    Weil, Joachim
    Boer, Jana
    KARDIOLOGIE, 2023, : 44 - 48
  • [35] Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction
    Raschi, Emanuel
    Diemberger, Igor
    Sabatino, Mario
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Potena, Luciano
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (03) : 303 - 320
  • [36] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Khan, Muhammad Nauman
    Soomro, Najia Aslam
    Naseeb, Khalid
    Bhatti, Usman Hanif
    Rauf, Rubina
    Balouch, Iram Jehan
    Moazzam, Ali
    Bashir, Sonia
    Ashraf, Tariq
    Karim, Musa
    BMC CARDIOVASCULAR DISORDERS, 2023, 23 (01)
  • [37] Sacubitril/valsartan reduces ventrucular arrhythmias in heart failure with reduced ejection fraction
    Lamaida, Norman
    Torella, Giorgio
    Cerciello, Antonio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N26 - N26
  • [38] Predictors of reverse left ventricular remodeling with sacubitril\valsartan therapy in heart failure and reduced ejection fraction
    Maizels, L.
    Wasserstrum, Y.
    Fishman, B.
    Segev, A.
    Ben-Nun, D.
    Younis, A.
    Freimark, D.
    Mazin, I.
    Grupper, A. Avishay
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 137 - 137
  • [39] Current evidence of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
    Abumayyaleh, Mohammad
    El-Battrawy, Ibrahim
    Behnes, Michael
    Borggrefe, Martin
    Akin, Ibrahim
    FUTURE CARDIOLOGY, 2020, 16 (04) : 227 - 236
  • [40] Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction
    Bruno, Rosa Maria
    Taddei, Stefano
    EUROPEAN HEART JOURNAL, 2017, 38 (15) : 1144 - 1146
12345